Bruce W. Dana

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

E A Neuwelt, David L. Goldman, Suellen A. Dahlborg et al. · Journal of Clinical Oncology · 1991 · 383 citations

Medicine, Neurology, Oncology +10

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

Bruce W. Dana, Steve Dahlberg, Bharat N. Nathwani et al. · Journal of Clinical Oncology · 1993 · 193 citations

Medicine, Oncology, Chemotherapy +13

Developments in the diagnosis and treatment of primary CNS lymphoma: A prospective series

Edward A. Neuwelt, Eugene P. Frenkel, Mary K. Gumerlock et al. · Cancer · 1986 · 123 citations · Full text

Medicine, Oncology, Pathology +17

Toxicity and Efficacy of Carboplatin and Etoposide in Conjunction with Disruption of the Blood-Brain Tumor Barrier in the Treatment of Intracranial Neoplasms

Paul C. Williams, W. David Henner, Roman-Goldstein Simon et al. · Neurosurgery · 1995 · 108 citations

Medicine, Oncology, Pharmacology +17

Interferon Alfa Consolidation After Intensive Chemotherapy Does Not Prolong the Progression-Free Survival of Patients With Low-Grade Non-Hodgkin’s Lymphoma: Results of the Southwest Oncology Group Randomized Phase III Study 8809

Richard I. Fisher, Bruce W. Dana, Michael LeBlanc et al. · Journal of Clinical Oncology · 2000 · 81 citations

Medicine, Oncology, Pharmacotherapy +14